Related Experiment Videos
Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA
M Ponti1, S M Forrow, R L Souhami
1Department of Oncology, University College and Middlesex School of Medicine, London, UK.
Abstract:
A polymerase stop assay has been developed to determine the DNA nucleotide sequence specificity of covalent modification by antineoplastic agents using the thermostable DNA polymerase from Thermus aquaticus and synthetic labelled primers. The products of linear amplification are run on sequencing gels to reveal the sites of covalent drug binding. The method has been studied in detail for a number of agents including nitrogen mustards, platinum analogues and mitomycin C, and the sequence specificities obtained accord with those obtained by other procedures. The assay is advantageous in that it is not limited to a single type of DNA lesion (as in the piperidine cleavage assay for guanine-N7 alkylation), does not require a strand breakage step, and is more sensitive than other primer extension procedures which have only one cycle of polymerization. In particular the method has considerable potential for examining the sequence selectivity of damage and repair in single copy gene sequences in genomic DNA from cells.
Insights
A new polymerase stop assay identifies DNA sequence-specific drug binding sites for anticancer agents. This sensitive method offers advantages over existing techniques for studying DNA damage and repair.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Antineoplastic agents can modify DNA, affecting cellular processes.
- Understanding sequence specificity of DNA modification is crucial for drug development.
- Existing methods for assessing DNA-drug interactions have limitations.
Purpose of the Study:
- To develop a sensitive polymerase stop assay for determining DNA nucleotide sequence specificity of covalent modification by antineoplastic agents.
- To evaluate the assay's performance with various anticancer drugs.
Main Methods:
- Utilized a thermostable DNA polymerase from Thermus aquaticus and synthetic labeled primers.
- Employed linear amplification and sequencing gel electrophoresis to detect drug binding sites.
- Studied nitrogen mustards, platinum analogues, and mitomycin C.
Main Results:
- The developed assay accurately determines DNA sequence specificity of covalent modification.
- Results for tested agents align with those from other established procedures.
- Demonstrated sensitivity and broad applicability for various DNA lesions.
Conclusions:
- The polymerase stop assay is a sensitive and versatile tool for studying DNA-drug interactions.
- It offers advantages over existing methods, including broader lesion detection and higher sensitivity.
- Has significant potential for investigating sequence-selective DNA damage and repair in genomic DNA.